The Partnership Clinically assess the efficacy and safety of moxifloxacin as a front-line agent for the treatment of TB.
{"Image DocumentName": "The PartnershipClinically assess the efficacy and safety of moxifloxacin as a front-line agent for the treatment of TB.", "Image ImageDescription": "If clinical trials are successful, register moxifloxacin for a TB indication. Committed to making the product affordable and accessible to patients in the developing world.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}